Imagenetix (IAGX) Stock Analysis & Winston Score
Imagenetix, Inc. is a small healthcare company that develops and sells nutritional supplements and over-the-counter health products. Its core offerings include joint health, pain relief, and wellness supplements sold mainly to consumers through retail channels and direct distribution. The company operates in the specialty health products space, competing alongside many other small supplement makers. Imagenetix makes money by selling its finished products to distributors, retailers, and directly to customers. It operates primarily in the United States and is a very small company, with a market cap that rounds to essentially zero, meaning it has limited financial resources compared to larger peers. Its gross margin of around 42% is reasonable for a supplement business, but its razor-thin operating margin of under 2% and very low return on invested capital suggest the company struggles to turn sales into meaningful profit — and sustaining growth while managing costs remains the central challenge it faces.
Winston Score: 23/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (10/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.00
Market Cap: $0M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
